ascendis transcon glp-1 program press #icymi #ascendispharma #transcontechnology GLP-1 Agonists: A Comprehensive Overview

Prescription GLP-1s work by acting as super sticky versions of gut hormones and that bind the same receptors that stimulate key pathways like appetite suppression and blood sugar regulation but much more powerfully and for longer periods (days or even weeks)

Data from the EVOKE clinical trial program provided the first direct evidence in humans, indicating that although the concentration of semaglutide in the cerebrospinal fluid (CSF) is low, it is detectable

But mitochondrial efficiency and NAD+ availability are distinct variables, and the evidence for NAD+ specifically addresses the fuel supply side of the equation

Stay tuned for more such updates on Digital Health News

Reasonable Incomplete Revascularization